| | | | | | | | | | |
| | |
 | Issue Date FY: 2021 ( Subtotal = $269,672,112 ) (Continued on the next page) |
| | 2021 | 2021 | U01DA050239 | Single-cell resolution analysis of chromatin accessibility and gene expression changes in a model of drug addiction | 001 | 2 | NIH | 4/30/2021 | 804355790 | $0 |
| | 2021 | 2021 | U01DA050239 | Single-cell resolution analysis of chromatin accessibility and gene expression changes in a model of drug addiction | 000 | 2 | NIH | 2/26/2021 | 804355790 | $695,538 |
| | 2021 | 2021 | R35GM134961 | Exploring Wnt-Fzd signaling specificities | 001 | 2 | NIH | 3/3/2021 | 804355790 | $44,843 |
| | 2021 | 2021 | R35GM134961 | Exploring Wnt-Fzd signaling specificities | 000 | 2 | NIH | 1/6/2021 | 804355790 | $403,589 |
| | 2021 | 2021 | R01DA049644 | Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Markets and Drug Tourism | 001 | 2 | NIH | 4/13/2021 | 804355790 | $116,144 |
| | 2021 | 2021 | R01DA049644 | Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Markets and Drug Tourism | 000 | 2 | NIH | 2/8/2021 | 804355790 | $1,208,754 |
| | 2021 | 2021 | R01GM117321 | The mutagenic chain reaction: a method for autocatalyic gene dissemination | 000 | 5 | NIH | 4/20/2021 | 804355790 | $323,644 |
| | 2021 | 2021 | R01MH107345 | Age related determinants of HAND: A 12 year follow-up of CHARTER participants | 001 | 5 | NIH | 5/5/2021 | 804355790 | $254,239 |
| | 2021 | 2021 | R01GM114362 | Computational methods for detecting patterns of complex genomic variation | 001 | 6 | NIH | 2/11/2021 | 804355790 | $28,949 |
| | 2021 | 2021 | R01GM114362 | Computational methods for detecting patterns of complex genomic variation | 000 | 6 | NIH | 12/21/2020 | 804355790 | $260,528 |
| | 2021 | 2021 | R01GM116897 | Suppression of duplication-mediated genome rearrangements by protein sumoylation | 000 | 7 | NIH | 3/2/2021 | 804355790 | $324,086 |
| | 2021 | 2021 | R01AR068987 | Ultrashort Echo Time (UTE) Magnetic Resonance Imaging of Bone | 000 | 6 | NIH | 3/29/2021 | 804355790 | $600,195 |
| | 2021 | 2021 | F32MH122192 | The role of VTA neurotransmitter co-release in health and disease | 001 | 2 | NIH | 2/5/2021 | 804355790 | $1,080 |
| | 2021 | 2021 | F32MH122192 | The role of VTA neurotransmitter co-release in health and disease | 000 | 2 | NIH | 12/11/2020 | 804355790 | $65,310 |
| | 2021 | 2021 | R01AG066088 | Sex-specific cognitive expression and risk in preclinical Alzheimer's disease | 000 | 2 | NIH | 4/1/2021 | 804355790 | $20,489 |
| | 2021 | 2021 | UM1AI069432 | Pooled and conventional nucleic acid testing strategies for SARS-CoV-2 to screen direct care research staff and protect HIV patients | 000 | 15 | NIH | 11/18/2020 | 804355790 | $648,446 |
| | 2021 | 2021 | UM1AI069432 | Pooled and conventional nucleic acid testing strategies for SARS-CoV-2 to screen direct care research staff and protect HIV patients | 000 | 15 | NIH | 11/18/2020 | 804355790 | $1,143,782 |
| | 2021 | 2021 | R01DC012595 | Innovative therapy for diseases of the middle ear | 000 | 8 | NIH | 2/26/2021 | 804355790 | $335,396 |
| | 2021 | 2021 | R01GM043644 | Mechanism of Auxin Action | 000 | 32 | NIH | 1/26/2021 | 804355790 | $276,924 |
| | 2021 | 2021 | U24DA041123 | ABCD-USA Consortium: Data Analysis, Informatics and Resource Center | 003 | 7 | NIH | 4/12/2021 | 804355790 | $1,020,000 |
| | 2021 | 2021 | U24DA041123 | ABCD-USA Consortium: Data Analysis, Informatics and Resource Center | 003 | 7 | NIH | 4/12/2021 | 804355790 | $2,902,509 |
| | 2021 | 2021 | U24DA041123 | ABCD-USA Consortium: Data Analysis, Informatics and Resource Center | 004 | 7 | NIH | 4/13/2021 | 804355790 | $291,722 |
| | 2021 | 2021 | T32AI007036 | Combating Antibiotic Resistance Into the Next Generation (CARING) | 000 | 41 | NIH | 4/29/2021 | 804355790 | $427,360 |
| | 2021 | 2021 | R01GM032373 | Biology of Sialic Acids and their Substitutions | 000 | 37 | NIH | 4/1/2021 | 804355790 | $521,147 |
| | 2021 | 2021 | T32MH018399 | Fellowship on Biological Psychiatry and Neuroscience | 000 | 35 | NIH | 4/7/2021 | 804355790 | $278,881 |
| | 2021 | 2021 | R01NS076896 | Mechanisms of Prion Spread | 000 | 10 | NIH | 4/13/2021 | 804355790 | $339,063 |
| | 2021 | 2021 | R01GM102362 | Molecular Mechanisms for DNA Damage Processing by Transcription Machinery | 000 | 9 | NIH | 2/10/2021 | 804355790 | $451,858 |
| | 2021 | 2021 | P42ES010337 | Harnessing Technological Innovation and Community-Engaged Implementation Science to Optimize COVID-19 Testing for Women and Children in Underserved Communities | 000 | 20 | NIH | 4/23/2021 | 804355790 | $2,634,787 |
| | 2021 | 2021 | R01DK018477 | Enhancer Connectomes in Regulation of Gene Expression | 000 | 45 | NIH | 12/30/2020 | 804355790 | $411,140 |
| | 2021 | 2021 | R01DK018477 | Enhancer Connectomes in Regulation of Gene Expression | 001 | 45 | NIH | 2/8/2021 | 804355790 | $45,682 |
| | 2021 | 2021 | R01MH094151 | Accelerated Inflammaging in Schizophrenia | 000 | 10 | NIH | 2/5/2021 | 804355790 | $743,472 |
| | 2021 | 2021 | R01DK098808 | Synergestic roles of SRF2 and RUNX1 in blood cell development and pathology | 000 | 8 | NIH | 4/30/2021 | 804355790 | $632,046 |
| | 2021 | 2021 | R01AI082850 | The 3D-Structures of the Immunoglobulin Heavy Chain Locus | 001 | 12 | NIH | 3/4/2021 | 804355790 | $381,890 |
| | 2021 | 2021 | K22CA229594 | Myeloid Syk promotes tumor immunosuppression and inhibits anti-tumor adaptive immunity | 000 | 2 | NIH | 11/6/2020 | 804355790 | $161,230 |
| | 2021 | 2021 | R01DK074482 | Molecular and functional dissection of the zebrafish hematopoietic stem cell niche | 000 | 15 | NIH | 11/24/2020 | 804355790 | $373,374 |
| | 2021 | 2021 | R01GM085490 | Cofactor-Mediated DNA Binding by the NF-kappaB Dimers | 000 | 10 | NIH | 3/12/2021 | 804355790 | $314,482 |
| | 2021 | 2021 | UM1AI069536 | HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU) Administrative Supplement | 000 | 15 | NIH | 11/23/2020 | 804355790 | $1,011,636 |
| | 2021 | 2021 | UM1AI069536 | HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU) Administrative Supplement | 000 | 15 | NIH | 11/23/2020 | 804355790 | $36,899 |
| | 2021 | 2021 | P30CA023100 | Specialized Cancer Center Support Grant | 002 | 35 | NIH | 4/30/2021 | 804355790 | $4,995,524 |
| | 2021 | 2021 | R01CA167426 | Role of PI3Kinase in Tumor Progression and Metastasis | 000 | 9 | NIH | 3/19/2021 | 804355790 | $295,139 |
| | 2021 | 2021 | R01CA182495 | Discovering Spatial Mechanisms Regulating Metastatic Invadopodia in PDAC | 001 | 7 | NIH | 5/10/2021 | 804355790 | $394,896 |
| | 2021 | 2021 | R01HS025440 | Distributed knowledge-based platform for radiotherapy plan quality control | 000 | 4 | AHRQ | 3/10/2021 | 804355790 | $374,613 |
| | 2021 | 2021 | R01DK122804 | Adipose tissue plasticity in health and disease | 000 | 2 | NIH | 4/19/2021 | 804355790 | $602,878 |
| | 2021 | 2021 | R01DC012797 | Age of acquisition effects on sign language development and brain processing | 000 | 8 | NIH | 11/24/2020 | 804355790 | $559,386 |
| | 2021 | 2021 | R01DC012797 | Age of acquisition effects on sign language development and brain processing | 001 | 8 | NIH | 1/7/2021 | 804355790 | $62,154 |
| | 2021 | 2021 | R01GM095970 | Protein-Protein Interactions in Natural Product Biosynthesis | 002 | 10 | NIH | 3/11/2021 | 804355790 | $7,741 |
| | 2021 | 2021 | R01DK039949 | Phase Separation: A New Phase in Decoding Enhancer-dependent Critical Transcriptional Programs by Nuclear Receptors | 000 | 39 | NIH | 3/15/2021 | 804355790 | $542,947 |
| | 2021 | 2021 | R01GM095970 | Protein-Protein Interactions in Natural Product Biosynthesis | 000 | 9 | NIH | 11/18/2020 | 804355790 | $12,887 |
| | 2021 | 2021 | R01GM095970 | Protein-Protein Interactions in Natural Product Biosynthesis | 001 | 10 | NIH | 1/20/2021 | 804355790 | $421,541 |
|
